LNNNY yields 6666.67% · JNJ yields 2.13%● Live data
📍 LNNNY pulled ahead of the other in Year 1
Combined, LNNNY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LNNNY + JNJ for your $10,000?
LEONI AG, together with its subsidiaries, provides products, solutions, and services for energy and data management in the automotive sector and other industries worldwide. It operates in two divisions, Wiring Systems, and Wire & Cable Solutions. The Wiring Systems division provides complete wiring systems and customized cable harnesses for the motor vehicle industry. Its products and services comprise cable harnesses through to integrated wiring systems, high-voltage wiring systems for hybrid and electric vehicles, energy distribution components, and special connectors, as well as related services. The Wire & Cable Solutions division manufactures and sells wire and cable systems; and provides energy transmission and data management system solutions. This segment offers a range of products and services, such as wires, strands, optical fibers, standardized cables, special cables, and fully assembled systems, as well as related services for customers in the automotive, capital goods, medical technology, telecommunications, energy, and infrastructure industries. The company was formerly known as Leonische Drahtwerke AG and changed its name to LEONI AG in 1999. The company was founded in 1569 and is headquartered in Nuremberg, Germany.
Full LNNNY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.